Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Tissue distribution favors areas with high GLP-1 and GIP receptor expression: pancreas, gut, brain, and adipose tissue
Insulin receptor and cancer
Key published studies include: Teichman et al., 2006 (JCEM): Dose-dependent GH and IGF-1 elevation with CJC-1295 DAC in healthy adults Raun et al., 1998 (Eur J Endocrinol): Ipamorelin demonstrated selective GH release without cortisol/prolactin elevation Johansen et al., 1999: Phase I/II Ipamorelin trial showed dose-response relationship with no significant adverse effects Bowers et al., 2004: Foundational research on GHRH/GHRP synergistic GH release mechanisms Neither CJC-1295 nor Ipamorelin has completed Phase 3 clinical trials
Nature 401 : 272276
Notably, research by Teichman et al
US$ 25.37
US$ 25.61
US$ 26.84
US$ 28.87
US$ 23.65
US$ 20.76
US$ 25.27
/assets/images/provider/photos/2802570.png)
